3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
36
Neoplasms, Plasma Cell
12
Prostatic Neoplasms
4
Neoplasms
3
Lymphoma, Mantle-Cell
3
Immunoglobulin Light-chain Amyloidosis
3
Central Nervous System Neoplasms
3
Waldenstrom Macroglobulinemia
2
Sarcoma
2
Recurrence
2
Rectal Neoplasms
2
Neuroblastoma
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Lung Neoplasms
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia
2
Glioma
2
Glioblastoma
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Amyloidosis
2
Adenocarcinoma of Lung
2
Renal Insufficiency, Chronic
1
Renal Insufficiency
1
Polyneuropathies
1
Paraproteinemias
1
Neurotoxicity Syndromes
1
Motor Activity
1
Interventions
Paclitaxel
96
Carboplatin
81
Bevacizumab
62
Gemcitabine
36
liposomal doxorubicin
32
pembrolizumab
30
Topotecan
26
olaparib
23
Taxes
23
niraparib
17
Immunoglobulin G
17
Disulfides
17
Docetaxel
16
Cyclophosphamide
16
Cisplatin
14
Nivolumab
11
rucaparib
10
durvalumab
10
Doxorubicin
9
Albumin-Bound Paclitaxel
8
sargramostim
7
pazopanib
7
fludarabine phosphate
7
fludarabine
7
avelumab
7
Magnetic Resonance Spectroscopy
7
Ifosfamide
7
epacadostat
6
Trabectedin
6
Sorafenib
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Ovarian Neoplasms
×
Thalidomide
×
Clear all
No trials found.